Shortage Notice: Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets

Shortage Notice: Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets

September 16, 2019

Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets, are currently experiencing temporary supply disruptions.

Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets have advised a resupply date of end of October 2019

Supplies are available from specialist importers on an ‘unlicensed’ basis. Ensure that where a prescriber wishes you to dispense an import, prescriptions are annotated ‘specials/unlicensed’ in the prescribing line and are endorsed as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP



Posted in:


More Latest News >

Self Care Week 2019

Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families,...

Final CPCS service spec published

Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community...

Ask PSNC: Flu FAQs

The services team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are...

PQS: NHSmail FAQs

The general NHSmail national helpdesk at NHS Digital has been receiving a number of queries from community pharmacy contractors about...